Javascript must be enabled to continue!
Use of the Cancer and Aging Research Group Predictive Model for Chemotherapy-Related Toxic Effects in a Multiethnic, Older Adult Asian Population
View through CrossRef
ImportanceThe Cancer and Aging Research Group (CARG) prediction model for chemotherapy-related toxic effects has been developed but not yet validated in older Asian adults. In view of differences in drug metabolism and toxic effect reporting in the Asian population, the ability of this tool to guide the cancer treatment decision-making process in older Asian adults needs to be assessed.ObjectiveTo examine the validity of the CARG predictive model in a multiethnic Asian cohort of older adults.Design, Setting, and ParticipantsIn this prognostic study, patients of various Asian ethnicities 70 years or older with a solid tumor diagnosis receiving chemotherapy at the National University Cancer Institute, Singapore, were accrued from June 1, 2017, to January 1, 2019. Their risks of chemotherapy-related toxic effects were calculated using the CARG tool. A geriatric assessment was performed, and the treating oncologist (blinded to the CARG scores) was asked to give an estimated likelihood of toxic effects (low, medium, or high). Chemotherapy-related toxic effects were recorded during each clinic visit. Validation of the prediction model was performed by calculating the area under the receiver operating characteristic curve. Multivariate analyses were performed to identify variables in other domains in the geriatric assessment predicting for severe toxic effects.Main Outcomes and MeasuresGrade 3 to 5 toxic effects and hospitalization.ResultsThe study included 200 patients (median age, 74 years [range, 70-89 years]; 110 [55.0%] male; 177 [88.5%] Chinese, 17 [8.5%] Malay, 4 [2.0%] Indian, and 2 [1.0%] other ethnicities [according to Singapore’s national system of race classification]). A total of 137 patients (68.5%) experienced grade 3 to 5 toxic effects, and 131 (65.5%) required hospitalization. The area under the receiver operating characteristic curve for the CARG chemotoxicity prediction model was 0.74 (95% CI, 0.67-0.82), retaining good discrimination in the study population.Conclusions and RelevanceThis prognostic study conducted in a multiethnic Asian cohort of older adults supports the validity of the CARG predictive model in this population, predicting which older adults are at risk of chemotherapy-related toxic effects.
American Medical Association (AMA)
Title: Use of the Cancer and Aging Research Group Predictive Model for Chemotherapy-Related Toxic Effects in a Multiethnic, Older Adult Asian Population
Description:
ImportanceThe Cancer and Aging Research Group (CARG) prediction model for chemotherapy-related toxic effects has been developed but not yet validated in older Asian adults.
In view of differences in drug metabolism and toxic effect reporting in the Asian population, the ability of this tool to guide the cancer treatment decision-making process in older Asian adults needs to be assessed.
ObjectiveTo examine the validity of the CARG predictive model in a multiethnic Asian cohort of older adults.
Design, Setting, and ParticipantsIn this prognostic study, patients of various Asian ethnicities 70 years or older with a solid tumor diagnosis receiving chemotherapy at the National University Cancer Institute, Singapore, were accrued from June 1, 2017, to January 1, 2019.
Their risks of chemotherapy-related toxic effects were calculated using the CARG tool.
A geriatric assessment was performed, and the treating oncologist (blinded to the CARG scores) was asked to give an estimated likelihood of toxic effects (low, medium, or high).
Chemotherapy-related toxic effects were recorded during each clinic visit.
Validation of the prediction model was performed by calculating the area under the receiver operating characteristic curve.
Multivariate analyses were performed to identify variables in other domains in the geriatric assessment predicting for severe toxic effects.
Main Outcomes and MeasuresGrade 3 to 5 toxic effects and hospitalization.
ResultsThe study included 200 patients (median age, 74 years [range, 70-89 years]; 110 [55.
0%] male; 177 [88.
5%] Chinese, 17 [8.
5%] Malay, 4 [2.
0%] Indian, and 2 [1.
0%] other ethnicities [according to Singapore’s national system of race classification]).
A total of 137 patients (68.
5%) experienced grade 3 to 5 toxic effects, and 131 (65.
5%) required hospitalization.
The area under the receiver operating characteristic curve for the CARG chemotoxicity prediction model was 0.
74 (95% CI, 0.
67-0.
82), retaining good discrimination in the study population.
Conclusions and RelevanceThis prognostic study conducted in a multiethnic Asian cohort of older adults supports the validity of the CARG predictive model in this population, predicting which older adults are at risk of chemotherapy-related toxic effects.
Related Results
Microwave Ablation with or Without Chemotherapy in Management of Non-Small Cell Lung Cancer: A Systematic Review
Microwave Ablation with or Without Chemotherapy in Management of Non-Small Cell Lung Cancer: A Systematic Review
Abstract
Introduction
Microwave ablation (MWA) has emerged as a minimally invasive treatment for patients with inoperable non-small cell lung cancer (NSCLC). However, whether it i...
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Abstract
The Physical Activity Guidelines for Americans (Guidelines) advises older adults to be as active as possible. Yet, despite the well documented benefits of physical a...
Abstract ED02-04: Intersection of cancer, aging, and survivorship
Abstract ED02-04: Intersection of cancer, aging, and survivorship
Abstract
Cancer is a disease associated with aging, with approximately 60% of cancer diagnoses occurring in patients age 65 and older. Of 10.8 million cancer survivo...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
ES6-3: Breast Cancer in the Older Adult.
ES6-3: Breast Cancer in the Older Adult.
Abstract
Breast cancer is a disease associated with aging. In the US, the median age of breast cancer diagnosis and death is 61 years and 68 years, respectively. The...
ecision Farming and Predictive Analytics in Precision Farming and Predictive Analytics in Precision Farming and Predictive Analytics in Precision Farming and Predictive Analytics in Precision Farming and Predictive Analytics in Precision Farming and Predi
ecision Farming and Predictive Analytics in Precision Farming and Predictive Analytics in Precision Farming and Predictive Analytics in Precision Farming and Predictive Analytics in Precision Farming and Predictive Analytics in Precision Farming and Predi
The scope of sensor networks and the Internet of Things spanning rapidly to diversified domains but not limited to sports, health, and business trading. In recent past, the sensors...
Shared Histories in Multiethnic Societies: Literature as a Critical Corrective of Cultural Memory Studies
Shared Histories in Multiethnic Societies: Literature as a Critical Corrective of Cultural Memory Studies
AbstractThe staging of history in literature is engaged in dynamic exchange with society’s memory discourses and in this context, literature is generally seen as playing a creative...
Abstract IA-08: Clinical advances in pancreas adenocarcinoma
Abstract IA-08: Clinical advances in pancreas adenocarcinoma
Abstract
Pancreatic adenocarcinoma (PDAC) remains one of the most lethal cancers today and is expected to be the second cause of cancer death in the coming decade. M...

